National Comorbidity Survey Replication Adolescent Supplement (NCS-A): II. Overview and Design - 08/08/11
, Shelli Avenevoli, Ph.D., E. Jane Costello, Ph.D., Jennifer Greif Green, Ph.D., Michael J. Gruber, M.S., Steven Heeringa, Ph.D., Kathleen R. Merikangas, Ph.D., Beth-Ellen Pennell, M.A., Nancy A. Sampson, B.A., Alan M. Zaslavsky, Ph.D.Disclosure: Dr. Kessler has been a consultant for GlaxoSmithKline, Kaiser Permanente, Pfizer, Sanofi-Aventis, Shire Pharmaceuticals, and Wyeth-Ayerst; has served on advisory boards for Eli Lilly and Wyeth-Ayerst; and has received research support for his epidemiological studies from Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Pharmaceuticals, Pfizer, and Sanofi-Aventis. The other authors report no conflicts of interest.
Abstract |
Objective |
To present an overview of the design and field procedures of the National Comorbidity Survey Replication Adolescent Supplement (NCS-A).
Method |
The NCS-A is a nationally representative face-to-face household survey of the prevalence and correlates of DSM-IV mental disorders among U.S. adolescents (aged 13–17 years) that was performed between February 2001 and January 2004 by the Survey Research Center of the Institute for Social Research at the University of Michigan. The sample was based on a dual-frame design that included 904 adolescent residents of the households that participated in the National Comorbidity Survey Replication (response rate 85.9%) and 9,244 adolescent students selected from a representative sample of 320 schools in the same nationally representative sample of counties as the National Comorbidity Survey Replication (response rate 74.7%).
Results |
Comparisons of sample and population distributions on census sociodemographic variables and, in the school sample, school characteristics documented only minor differences that were corrected with poststratification weighting. Comparisons of DSM-IV disorder prevalence estimates among household versus school sample respondents in counties that differed in the use of replacement schools for originally selected schools that refused to participate showed that the use of replacement schools did not introduce bias into prevalence estimates.
Conclusions |
The NCS-A is a rich nationally representative dataset that will substantially increase understanding of the mental health and well-being of adolescents in the United States.
Le texte complet de cet article est disponible en PDF.Key Words : National Comorbidity Survey Replication Adolescent Supplement, mental disorders, epidemiology, survey design, survey sampling
Plan
| The National Comorbidity Survey Replication Adolescent Supplement (NCS-A) is supported by the National Institute of Mental Health (NIMH; Grant U01-MH60220) with supplemental support from the National Institute on Drug Abuse, the Substance Abuse and Mental Health Services Administration, the Robert Wood Johnson Foundation (Grant 044780), and the John W. Alden Trust. The work of Dr. Merikangas and her staff on the NCS-A is supported by the NIMH Intramural Research Program, whereas the work of Dr. Zaslavsky and his staff on the validity of the NCS-A measures is supported by NIMH Grant R01-MH66627. The views and opinions expressed in this article are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or U.S. Government. A complete list of NCS-A publications can be found at ncs. The NCS-A is performed in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The authors thank the staff of the WMH Data Collection and Data Analysis Coordination Centers for assistance with instrumentation, fieldwork, and consultation on data analysis. The WMH Data Coordination Centers have received support from NIMH (Grants R01-MH070884, R13-MH066849, R01-MH069864, and R01-MH077883), NIDA (Grant R01-DA016558), the Fogarty International Center of the National Institutes of Health (FIRCA R03-TW006481), the John D. and Catherine T MacArthur Foundation, the Pfizer Foundation, and the Pan American Health Organization. The WMH Data Coordination Centers have also received unrestricted educational grants from Astra Zeneca, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Ortho-McNeil, Pfizer, Sanofi-Aventis, and Wyeth. A complete list of WMH publications can be found at wmh/. The authors thank Steven Heeringa, Ph.D., and Alan Zaslavsky, Ph.D., for statistical expertise. This article is the subject of an editorial by Dr. Peter Szatmari in this issue. |
Vol 48 - N° 4
P. 380-385 - avril 2009 Retour au numéro
Article précédent
- National Comorbidity Survey Replication Adolescent Supplement (NCS-A): I. Background and Measures
- Kathleen R. Merikangas, Shelli Avenevoli, E. Jane Costello, Doreen Koretz, Ronald C. Kessler
- National Comorbidity Survey Replication Adolescent Supplement (NCS-A): III. Concordance of DSM-IV/CIDI Diagnoses With Clinical Reassessments
- Ronald C. Kessler, Shelli Avenevoli, Jennifer Green, Michael J. Gruber, Margaret Guyer, Yulei He, Robert Jin, Joan Kaufman, Nancy A. Sampson, Alan M. Zaslavsky, Kathleen R. Merikangas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?